125 related articles for article (PubMed ID: 21371209)
1. Mycobacterium tuberculosis in a HIV-1-infected population from Southeastern Brazil in the HAART era.
Pedro HS; Pereira MI; Goloni MR; Pires FC; Oliveira RS; da Rocha MA; Conceição LM; Fraga VD; Fenley JC; Cordeschi T; Machado RL; Franco C; Rossit AR
Trop Med Int Health; 2011 Jan; 16(1):67-73. PubMed ID: 21371209
[TBL] [Abstract][Full Text] [Related]
2. Disseminated nontuberculous mycobacterial disease in patients with acquired immune deficiency syndrome in the south of Brazil.
Dos Santos RP; Scheid K; Goldani LZ
Trop Doct; 2010 Oct; 40(4):211-3. PubMed ID: 20643867
[TBL] [Abstract][Full Text] [Related]
3. Brief report: disseminated mycobacteriosis caused by drug-resistant Mycobacterium triplex in a human immunodeficiency virus-infected patient during highly active antiretroviral therapy.
Cingolani A; Sanguinetti M; Antinori A; Larocca LM; Ardito F; Posteraro B; Federico G; Fadda G; Ortona L
Clin Infect Dis; 2000 Jul; 31(1):177-9. PubMed ID: 10913418
[TBL] [Abstract][Full Text] [Related]
4. Mycobacterium kansasii in HIV patients: clarithromycin and antiretroviral effects.
Tompkins JC; Witzig RS
Int J Tuberc Lung Dis; 2007 Mar; 11(3):331-7. PubMed ID: 17352101
[TBL] [Abstract][Full Text] [Related]
5. Psychosocial impact of poverty on antiretroviral nonadherence among HIV-TB coinfected patients in Lima, Peru.
Shin S; Muñoz M; Espiritu B; Zeladita J; Sanchez E; Callacna M; Rojas C; Arevalo J; Wu Y; Caldas A; Sebastian JL
J Int Assoc Physicians AIDS Care (Chic); 2008; 7(2):74-81. PubMed ID: 18319510
[TBL] [Abstract][Full Text] [Related]
6. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
Ives NJ; Gazzard BG; Easterbrook PJ
J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of pulmonary tuberculosis among HIV-infected persons in a home care program in Phnom Penh, Cambodia.
Kimerling ME; Schuchter J; Chanthol E; Kunthy T; Stuer F; Glaziou P; Ee O
Int J Tuberc Lung Dis; 2002 Nov; 6(11):988-94. PubMed ID: 12475145
[TBL] [Abstract][Full Text] [Related]
8. Drug susceptibility profile of Mycobacterium tuberculosis isolated from HIV infected and uninfected pulmonary tuberculosis patients in eastern India.
Chakraborty N; De C; Bhattacharyya S; Mukherjee A; Santra S; Banerjee D; Sarkar RN; Guha SK
Trans R Soc Trop Med Hyg; 2010 Mar; 104(3):195-201. PubMed ID: 19828165
[TBL] [Abstract][Full Text] [Related]
9. Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection.
Breen RA; Smith CJ; Bettinson H; Dart S; Bannister B; Johnson MA; Lipman MC
Thorax; 2004 Aug; 59(8):704-7. PubMed ID: 15282393
[TBL] [Abstract][Full Text] [Related]
10. [Bacteremia in tuberculosis and other mycobacterial infections].
Puzanov VA; Kosareva MV
Probl Tuberk; 1999; (1):54-9. PubMed ID: 10199188
[No Abstract] [Full Text] [Related]
11. Bone marrow aspiration, biopsy, and culture in the evaluation of HIV-infected patients for invasive mycobacteria and histoplasma infections.
Akpek G; Lee SM; Gagnon DR; Cooley TP; Wright DG
Am J Hematol; 2001 Jun; 67(2):100-6. PubMed ID: 11343381
[TBL] [Abstract][Full Text] [Related]
12. Immune restoration disease in HIV patient.
Jenkins NE; Beadsworth MB; Anson JJ; Nye FJ; Martlew VJ; Beeching NJ
Emerg Infect Dis; 2006 Apr; 12(4):689-91. PubMed ID: 16704824
[TBL] [Abstract][Full Text] [Related]
13. Cytokine responses induced by Mycobacterium tuberculosis in patients with HIV-1 infection and tuberculosis.
Oh MD; Kang CI; Kim US; Kim NJ; Lee B; Kim HB; Choe KW
Int J Infect Dis; 2005 Mar; 9(2):110-6. PubMed ID: 15708327
[TBL] [Abstract][Full Text] [Related]
14. Oral Candida colonization and its relation with predisposing factors in HIV-infected children and their uninfected siblings in Brazil: the era of highly active antiretroviral therapy.
Cerqueira DF; Portela MB; Pomarico L; de Araújo Soares RM; de Souza IP; Castro GF
J Oral Pathol Med; 2010 Feb; 39(2):188-94. PubMed ID: 20040023
[TBL] [Abstract][Full Text] [Related]
15. Systemic mycobacterioses in AIDS patients as determined by blood cultures on biphasic medium.
Aily DC; Camargo SS; Paro HS; Passos CA; Coelho AG; Sato DN; Shikama ML; Silva RR; Ueki SY
Rev Argent Microbiol; 1999; 31(2):53-7. PubMed ID: 10425659
[TBL] [Abstract][Full Text] [Related]
16. AIDS-associated cryptococcosis: a comparison of epidemiology, clinical features and outcome in the pre- and post-HAART eras. Experience of a single centre in Italy.
Antinori S; Ridolfo A; Fasan M; Magni C; Galimberti L; Milazzo L; Sollima S; Adorni F; Giuliani G; Galli M; Corbellino M; Parravicini C
HIV Med; 2009 Jan; 10(1):6-11. PubMed ID: 19125961
[TBL] [Abstract][Full Text] [Related]
17. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era.
Madeddu G; Porqueddu EM; Cambosu F; Saba F; Fois AG; Pirina P; Mura MS
Infection; 2008 Jun; 36(3):231-6. PubMed ID: 18463787
[TBL] [Abstract][Full Text] [Related]
18. Post-HAART tuberculosis in adults and adolescents with HIV in India: incidence, clinical and immunological profile.
Rajasekaran S; Raja K; Jeyaseelan L; Vijilat S; Priya K; Mohan K; Parvez A; Mahilmaran A; Chandrasekar C
Indian J Tuberc; 2009 Apr; 56(2):69-76. PubMed ID: 19810588
[TBL] [Abstract][Full Text] [Related]
19. Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy.
Dheda K; Lampe FC; Johnson MA; Lipman MC
J Infect Dis; 2004 Nov; 190(9):1670-6. PubMed ID: 15478074
[TBL] [Abstract][Full Text] [Related]
20. Declining prevalence of drug-resistant tuberculosis among HIV/tuberculosis co-infected patients receiving antiretroviral therapy.
Sungkanuparph S; Eampokalap B; Chottanapund S; Bed ST; Manosuthi W
J Med Assoc Thai; 2007 May; 90(5):884-8. PubMed ID: 17596041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
